Cefuroxime Safety in G6PD Deficiency Patients
Understanding G6PD Deficiency and Medication Safety
- The severity of G6PD deficiency varies based on genetic variant and ethnic background, with the Mediterranean variant (Gdmed) typically causing more severe reactions than the African variant (GdA-) 2, 1
Medications Contraindicated in G6PD Deficiency
- Primaquine is contraindicated in G6PD deficiency, as it can cause severe hemolytic anemia in affected patients 2
- Rasburicase is contraindicated in G6PD deficiency, as it can cause severe hemolytic anemia in affected patients 1
- Methylthioninium chloride (methylene blue) is contraindicated in G6PD deficiency, as it can cause severe hemolytic anemia in affected patients 1
Clinical Considerations
- Screening for G6PD deficiency is recommended before starting therapy with oxidant drugs in patients with predisposing racial or ethnic backgrounds (Mediterranean, African, Indian, or Southeast Asian descent) 2, 1
- When treating G6PD-deficient patients, it's essential to monitor for signs of hemolysis, including jaundice, dark urine, fatigue, and pallor, especially when starting any new medication 1
Practical Recommendations
- For patients with severe G6PD deficiency and multiple comorbidities, consider monitoring hemoglobin levels after initiating treatment with cefuroxime, though this is not routinely necessary 1